Our experiments were therefore structured to test an a priori the working hypothesis that XFK mitigates pyroptosis in CHF by upregulating miR-223 and inhibiting NF-κB/NLRP3 related signaling, using gain- and loss-of-function and rescue approaches. The gene discussed is NLRP3; the disease is congestive heart failure.